| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |